342 related articles for article (PubMed ID: 26726739)
1. Medicinal Chemistry Focusing on Aggregation of Amyloid-β.
Sohma Y
Chem Pharm Bull (Tokyo); 2016; 64(1):1-7. PubMed ID: 26726739
[TBL] [Abstract][Full Text] [Related]
2. Covalent modifier-type aggregation inhibitor of amyloid-β based on a cyclo-KLVFF motif.
Kino R; Araya T; Arai T; Sohma Y; Kanai M
Bioorg Med Chem Lett; 2015 Aug; 25(15):2972-5. PubMed ID: 26045033
[TBL] [Abstract][Full Text] [Related]
3. [Amyloid-selective Photooxygenation toward Treatment for Amyloid Diseases].
Taniguchi A
Yakugaku Zasshi; 2018; 138(1):47-53. PubMed ID: 29311465
[TBL] [Abstract][Full Text] [Related]
4. A new class of aggregation inhibitor of amyloid-β peptide based on an O-acyl isopeptide.
Kawashima H; Sohma Y; Nakanishi T; Kitamura H; Mukai H; Yamashita M; Akaji K; Kiso Y
Bioorg Med Chem; 2013 Nov; 21(21):6323-7. PubMed ID: 24076366
[TBL] [Abstract][Full Text] [Related]
5. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
Savelieff MG; DeToma AS; Derrick JS; Lim MH
Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and evaluation of Trolox-conjugated amyloid-β C-terminal peptides for therapeutic intervention in an in vitro model of Alzheimer's disease.
Arai T; Ohno A; Kazunori M; Kakizawa T; Kuwata H; Ozawa T; Shibanuma M; Hara S; Ishida S; Kurihara M; Miyata N; Nakagawa H; Fukuhara K
Bioorg Med Chem; 2016 Sep; 24(18):4138-4143. PubMed ID: 27407032
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of the aggregation and neurotoxicity of amyloid-β peptides by catalytic photooxygenation.
Taniguchi A; Sasaki D; Shiohara A; Iwatsubo T; Tomita T; Sohma Y; Kanai M
Angew Chem Int Ed Engl; 2014 Jan; 53(5):1382-5. PubMed ID: 24339209
[TBL] [Abstract][Full Text] [Related]
8. Virtual and In Vitro Screens Reveal a Potential Pharmacophore that Avoids the Fibrillization of Aβ1-42.
Hernández-Rodríguez M; Correa-Basurto J; Nicolás-Vázquez MI; Miranda-Ruvalcaba R; Benítez-Cardoza CG; Reséndiz-Albor AA; Méndez-Méndez JV; Rosales-Hernández MC
PLoS One; 2015; 10(7):e0130263. PubMed ID: 26172152
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of amyloid-β aggregation in Alzheimer's disease.
Wang Q; Yu X; Li L; Zheng J
Curr Pharm Des; 2014; 20(8):1223-43. PubMed ID: 23713775
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of a highly soluble Aβ
LeVatte MA; Lipfert M; Ladner-Keay C; Wishart DS
Protein Expr Purif; 2019 Dec; 164():105480. PubMed ID: 31425755
[TBL] [Abstract][Full Text] [Related]
11. Development of click peptide: stimuli-responsive precursor producing Alzheimer's disease-related amyloid beta peptide.
Taniguchi A
Yakugaku Zasshi; 2009 Oct; 129(10):1227-32. PubMed ID: 19797878
[TBL] [Abstract][Full Text] [Related]
12. The inhibitory mechanism of a fullerene derivative against amyloid-β peptide aggregation: an atomistic simulation study.
Sun Y; Qian Z; Wei G
Phys Chem Chem Phys; 2016 May; 18(18):12582-91. PubMed ID: 27091578
[TBL] [Abstract][Full Text] [Related]
13. The 'O-acyl isopeptide method' for the synthesis of difficult sequence-containing peptides: application to the synthesis of Alzheimer's disease-related amyloid beta peptide (Abeta) 1-42.
Sohma Y; Hayashi Y; Kimura M; Chiyomori Y; Taniguchi A; Sasaki M; Kimura T; Kiso Y
J Pept Sci; 2005 Jul; 11(8):441-51. PubMed ID: 15761877
[TBL] [Abstract][Full Text] [Related]
14. Determining binding sites of polycyclic aromatic small molecule-based amyloid-beta peptide aggregation modulators using sequence-specific antibodies.
Irwin JA; Edward Wong H; Kwon I
Anal Biochem; 2015 Feb; 470():61-70. PubMed ID: 25449301
[TBL] [Abstract][Full Text] [Related]
15. 'Click peptide' using production of monomer Aβ from the O-acyl isopeptide: application to assay system of aggregation inhibitors and cellular cytotoxicity.
Sohma Y; Hirayama Y; Taniguchi A; Mukai H; Kiso Y
Bioorg Med Chem; 2011 Mar; 19(5):1729-33. PubMed ID: 21330139
[TBL] [Abstract][Full Text] [Related]
16. Modulating amyloid-β aggregation: The effects of peptoid side chain placement and chirality.
Turner JP; Chastain SE; Park D; Moss MA; Servoss SL
Bioorg Med Chem; 2017 Jan; 25(1):20-26. PubMed ID: 27776890
[TBL] [Abstract][Full Text] [Related]
17. "Click peptides"--chemical biology-oriented synthesis of Alzheimer's disease-related amyloid beta peptide (abeta) analogues based on the "O-acyl isopeptide method".
Sohma Y; Kiso Y
Chembiochem; 2006 Oct; 7(10):1549-57. PubMed ID: 16915597
[TBL] [Abstract][Full Text] [Related]
18. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
19. Modification of a small β-barrel protein, to give pseudo-amyloid structures, inhibits amyloid β-peptide aggregation.
Murakoshi Y; Takahashi T; Mihara H
Chemistry; 2013 Apr; 19(14):4525-31. PubMed ID: 23371795
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of amyloid fibril formation and cytotoxicity by caffeic acid-conjugated amyloid-β C-terminal peptides.
Arai T; Ohno A; Mori K; Kuwata H; Mizuno M; Imai K; Hara S; Shibanuma M; Kurihara M; Miyata N; Nakagawa H; Fukuhara K
Bioorg Med Chem Lett; 2016 Nov; 26(22):5468-5471. PubMed ID: 27789140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
